But diabetes management and weight loss are far from the most interesting things about semaglutide. In fact, the more we learn about biochemical pathways that this class of drug targets, the more ...

stroke and CV death in those treated with oral semaglutide vs placebo. The proven cardiovascular benefit reflects a profound clinical impact for our patients who now have an oral option to improve ...

and pain levels before and after starting semaglutide, as well as biochemical markers, including C-reactive protein (CRP), glucose and haemoglobin A1c (HbA1c) levels. The results showed marked ...